MELISSA BAKER: Open Payments
NPI 1598451197 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,636 in 120 payments from 21 companies in 2025. Trend: 2023 $39 · 2024 $2,236 · 2025 $4,636
Food & beverage: $3,294Consulting: $1,195Education: $147
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4 | $1,372 |
| ABBVIE INC. | 26 | $805 |
| Janssen Biotech, Inc. | 13 | $568 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $309 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $222 |
| Ardelyx, Inc. | 7 | $193 |
| PFIZER INC. | 9 | $183 |
| Lilly USA, LLC | 7 | $158 |
| GENZYME CORPORATION | 6 | $154 |
| Madrigal Pharmaceuticals | 3 | $126 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, XIFAXAN, RINVOQ, IBSRELA, LINZESS, ENTYVIO.
Industry payments across MI — which companies pay providers there.
